The valyl-transfer ribonucleic acid (tRNA) synthetase of Escherichia coli strain NP2907, previously described as having an elevated Km for adenosine triphosphate and reduced stability in vitro compared to the wild type, was found to be conditionally thermolabile in vivo. The rate of inactivation of this enzyme at a particular temperature appears to be coordinated with the rate of growth; at 40 C this coordination results in equal rates of synthesis and destruction over a wide range of growth rates. In vitro studies showed that conditions favoring maintenance of the valyl-tRNA synthetase-valyl adenylate complex conferred complete protection against inactivation at 40 C, whereas the further addition of uncharged tRNA caused rapid, irreversible decay. We propose that the rate of inactivation of this mutant valyl-tRNA synthetase in vivo is a function of the ratio of deacylated to acylated tRNAvsl and that this ratio is a function of growth rate. The event which renders the valyl-tRNA synthetase susceptible to inactivation is likely to be the normal breakdown of the valyl-tRNA synthetase-valyl-adenylate complex during a cycle of aminoacylation of tRNAVa'.
The valyl-transfer ribonucleic acid (tRNA) synthetase of Escherichia coli strain NP2907, previously described as having an elevated Km for adenosine triphosphate and reduced stability in vitro compared to the wild type, was found to be conditionally thermolabile in vivo. The rate of inactivation of this enzyme at a particular temperature appears to be coordinated with the rate of growth; at 40 C this coordination results in equal rates of synthesis and destruction over a wide range of growth rates. In vitro studies showed that conditions favoring maintenance of the valyl-tRNA synthetase-valyl adenylate complex conferred complete protection against inactivation at 40 C, whereas the further addition of uncharged tRNA caused rapid, irreversible decay. We propose that the rate of inactivation of this mutant valyl-tRNA synthetase in vivo is a function of the ratio of deacylated to acylated tRNAvsl and that this ratio is a function of growth rate. The event which renders the valyl-tRNA synthetase susceptible to inactivation is likely to be the normal breakdown of the valyl-tRNA synthetase-valyl-adenylate complex during a cycle of aminoacylation of tRNAVa'.
Escherichia coli strain NP2907, possessing an altered valyl-transfer ribonucleic acid (tRNA) synthetase (VRS), has been described (1) . The unique feature of this strain is the apparent dependence of the intracellular valyltRNA synthetase concentration upon the temperature of cultivation of the cells. At a particular temperature, the level of detectable VRS which can be sustained is constant over a wide range of growth rates which are nutritionally set. At 40 C, the cells can apparently produce no VRS, and when they are shifted from 30 to 40 C the enzyme concentration declines at the same rate that protein is synthesized. The result is a dilution of VRS activity, and the enzyme level per milliliter of culture remains constant.
Two possibilities can be entertained to explain this phenomenon. The first is that the 1 The studies reported here are taken from a thesis submitted by James J. Anderson to Purdue University in partial fulfillment of the requirements for the Ph.D. degree. A preliminary report of some of these findings has appeared (14) . 2 Present address: Department of Biological Sciences, Dartmouth College, Hanover, N.H. 03755. 3Present address: Department of Microbiology, The University of Michigan, Ann Arbor, Mich. 48104. synthesis of VRS is temperature-sensitive and that VRS once formed is thermostable. At 40 C, the synthesis of new VRS would be precluded, and only preexisting enzyme would remain active, to be diluted out by continued protein synthesis. The second possibility is that the rates of synthesis and inactivation of VRS are coordinated in such a manner that the measurable concentration (units/milligram of total protein) of VRS is a net balance between the two rates; at 40 C these rates would be equal, resulting in no net accumulation.
The former possibility was advocated in a previous note (Anderson and Neidhardt, Bacteriol. Proc., p. 118, 1968), and there are several precedents in the literature for the temperature-sensitive synthesis of proteins. Sadler and Novick (16) reported a mutationally generated temperature-sensitive synthesis of the repressor protein of the E. coli lac operon; Kornberg and Smith (11) have isolated a temperature-sensitive synthesis mutant of the E. coli isocitrate lyase; and Condon and Ingraham (3) have discovered temperature-sensitive synthesis of the muconate lactonizing enzyme in a mutant of Pseudomonas putida. We found, as did these workers for their systems, that the 315 VRS of strain NP2907 was apparently inherently stable at 40 C when media conditions precluded new VRS synthesis. This evidence, together with the demonstration that detectable cross-reacting material (to antibody prepared against wild-type VRS) did not accumulate at 40 C, suggested that our first conclusion was correct.
Unequivocal proof, however, required the positive identification of preexisting, thermostable VRS in a growth situation where de novo VRS synthesis should be halted. A convenient tool for this study was provided by the density shift technique originally suggested for proteins by Hu, Bock, and Halvorson (7), and recently employed by Chrispeels et al. (2) , and Williams and Neidhardt (19) to resolve problems of aminoacyl-tRNA synthetase formation. Briefly, cellular protein is labeled with deuterium by growth in deuterium oxide under one set of conditions, thus labeling the enzyme of choice, and then shifting to the conditions of interest in H20, such that any new proteins synthesized will be unlabeled. The preexisting "heavy" and de novo "light" proteins are readily separable on CsCl density gradients after centrifugation to equilibrium. No prior purification of the enzyme is required.
We now report that new VRS is indeed synthesized at 40 C in strain NP2907. The evidence strongly suggests the bizarre coordination of synthesis and inactivation of VRS, the degree of which sets the maximum concentration of VRS the cells can sustain, and which concentration diminishes to zero as the temperature approaches 40 C.
Based on the in vitro stability characteristics of the mutant VRS, we propose a model which relates the rate of inactivation to the in vivo functional state of the VRS vis a vis its substrates and products.
MATERIALS AND METHODS
Organisms. E. coli strains NP2 (wild type), NP29 (a primary mutant of strain NP2), and NP2907 were described previously (1) .
Media and methods of cultivation. Media were prepared as in the accompanying paper (1), with the following exception. The components of the minimal medium involved in deuterium-labeling studies were dissolved in 99.75% D2O (Volk Radiochemicals) rather than H2O. L-Valine (150 yg/ml) and L-isoleucine (50 Ag/ml) were present in all minimal media unless specifically noted otherwise.
Shifts from D20 to H2O media were accomplished by quickly chilling the D20 culture and centrifuging the cells at 9,000 x g at 0 C for 10 min. The pelleted cells were washed twice with H2O medium at 0 C and then resuspended in a small volume of the cold medium. This suspension was then rapidly diluted at least ten-fold into prewarmed H2O medium at the appropriate temperature. Growth was monitored by optical density at 420 nm with a Beckman model DB spectrophotometer.
Bacterial cultures were slowly adapted to D2O by successive growth for at least five generations in 25, 50, 80, and then 95% D2O minimal medium before use in experiments. Unless specifically noted, cultures were always sampled at cell densities which were consistent with balanced growth.
Preparation of extracts. Crude extracts were prepared from rapidly chilled culture samples as described previously (1) . The washed cells were sonically disrupted in 0.1 M tris(hydroxymethyl)aminomethane (Tris)-hydrochloride, pH 7.3, containing 0.001 M L-valine and 0.006 M 2-mercaptoethanol (TVM buffer), and centrifuged at 9,000 x g to remove whole cells and debris. The clarified extracts were assayed for VRS activity within 24 hr, except for the equilibrium centrifugation studies and the in vitro analysis of VRS stability, which required the following purification to remove nucleic acid.
Extracts of strains NP2 and NP2907 were further centrifuged at 100,000 x g for 2.5 hr in TVM buffer containing 0.01 M MgCl2. The pellet was discarded, and the supernatant liquid was titrated with 10% streptomycin sulfate solution to a final concentration of 2% streptomycin. After centrifugation at 10,000 x g for 30 min, the precipitate was discarded, and the supernatant liquid was exhaustively dialyzed against TVM. The extracts were made 25% in glycerol and stored at 0 C where they retained activity for months. Immediately before use, samples were passed through columns of Sephadex G-25, equilibrated with TVM buffer, to remove small molecules. These preparations contained less than 1% RNA by ultraviolet absorption (280/260 nm).
Aminoacyl-tRNA synthetase assay. The measurement of the aminoacylation of tRNA (General Biochemicals, from E. coli K-12) has been described (1). In several experiments which measured the stability of VRS in incomplete reaction mixtures at varying temperatures, the assays were performed in the following way. A solution (0.5 ml) containing the usual proportions of Tris buffer, MgCl2, KCl, glutathione, '4C-L-valine, and bovine serum albumin was supplemented with 0.5 unit of inorganic pyrophosphatase (Worthington), nucleic acid-free crude extract of strains NP2 or NP2907, and combinations of adenosine triphosphate (ATP) and tRNA. At intervals of incubation at elevated temperature, including a zero point, 0.1-ml samples were taken and rapidly pipetted into 0.4 ml of a complete reaction mixture at 30 C. From the latter tube, 0.1-ml samples were periodically removed and pipetted into 3 ml of 5% trichloroacetic acid containing 1 mg of D,L-valine at 0 C. After 39 min, the precipitates were collected by filtration onto cellulose acetate filters (Schleicher and Schuell, B4) and washed with 5% trichloroacetic acid-valine (two 5-ml rinses) and finally with 5 ml of 67% ethanol. The filters were air dried and counted in a toluene-based scintillation fluid with a Packard liquid scintillation counter.
Isopycnic centrifugation in cesium chloride. The isopycnic centrifugation procedure used was STABILITY OF MUTANT VALYL-tRNA SYNTHETASE that of Williams and Neidhardt (19) . Centrifugations were carried out in a Beckman-Spinco SW39L rotor with a Spinco model L-4 ultracentrifuge. The 5.0-ml centrifuge tubes contained the following: 1 ml of saturated CsCl (Harshaw) in water at 25 C; 2 ml of TVM buffer containing up to 1.5 mg of crude bacterial protein; and 1.5 ml of mineral oil layered on top. The tubes were centrifuged at 39,000 rev/min for 60 to 70 hr at 5 C. After centrifugation the tubes were pierced through the bottom and six-drop fractions were collected. Samples (10 Mliters) were removed from each fraction and assayed in the usual aminoacylation reaction. The CsCl gradient was monitored by the refractive index of the remaining fraction volume with a Zeiss refractometer, and particular values were converted to density (grams/milliliter) by means of a standard curve.
Quantitative microcomplement fixation. The method of Wasserman and Levine (18) for microcomplement fixation was used without modification. Basically, the assay measures the formation of antibody-antigen complexes through their specific inactivation (fixation) of complement. The assay was performed in two steps. (i) A fixed quantity of antibody to VRS (a gift of M. Yaniv) was titrated with increasing concentrations of the antigen in the presence of fixed quantity of complement (guinea pig, Difco). Incubation to completion was permitted for 18 hr at 4 C. (ii) Unfixed complement was measured by adding sheep red blood cells which had been sensitized with anti-sheep hemolysin (Difco), and lysis was permitted at 37 C for 1 hr. The solubilized hemoglobin was measured spectrophotometrically at 413 nm. Within defined limits of the assay, the amount of hemoglobin released is an inverse measure of the quantity of antigen-antibody complex present. Results are expressed as C'H50 units fixed versus antigen concentration, where 1 C'H50 unit equals that dilution of complement which will cause 50% lysis of sensitized red blood cells.
Crude extracts of E. coli strains NP2 and NP2907 were the source of the VRS antigen; these extracts were prepared in 0.006 M potassium phosphate buffer (pH 7.3) containing 0.006 M 2-mercaptoethanol. All procedures for measurement of complement activity, sensitization of red blood cells, and preparation of reagents were taken from Kabat and Mayer (8) .
Calculation of the rate of synthesis of VRS from density shift data. The unique properties of strain NP2907 allowed a simpler method of analysis than that employed by Williams and Neidhardt (19) .
At 40 C the rates of synthesis, v8, and inactivation, Vd, must be identical since the amount of VRS per milliliter of culture remains constant. That is, V= Vd1)
To measure the true rate of synthesis of new enzyme, therefore, it is sufficient to measure the rate of inactivation of preexisting VRS, which is simplified by the density shift method discussed above. If prelabeled enzyme is Eh (units/milliliter of culture),
Where Et = total enzyme measured. Integrating, ln Eh2 -ln Ehl = (vd/Et) (t2 -tQ) ( 3) For the sake of convenience, since the rate of VRS synthesis relative to the previous rate at 30 C is of issue, let Eh, = 1. Then the relation is simplified to ln Eh2 = Vd (t2 -tl) (
If, during this interval, an amount Q of new enzyme is made, Q = v8(t2 -tl) then, combining (1), (5), and (4), ln Eh2 = -Q (5) (6) Which relates the amount of new synthesis of VRS to the measurable loss of the old enzyme.
Measurement of the rate of synthesis of VRS at 30 C proceeds simply because the specific activity of the culture is not changing. Therefore, the amount of inactivation of preexisting VRS, which is simply measured by the density shift technique described above, can be added on to the measurable amount of new VRS made to obtain the true rate of synthesis of new enzyme.
RESULTS
In vivo stability of the mutant valyltRNA synthetase at 40 C.The experiments depicted in Fig. 1 and 2 were employed to examine the in vivo thermostability of the VRS of strain NP2907 in environments which would not permit protein (new VRS) synthesis. Figure 1 shows that, when cultures of strain NP2907 were shifted from growth at 30 C in rich broth to a 40 C salt solution, the VRS activity remained stable in the presence of external L-valine but declined gradually if the amino acid was omitted. The initially rapid rate of inactivation slows upon continued starvation, perhaps because of endogenous generation of intracellular L-valine from protein turnover. In the same figure, the ability of the two cultures to resume growth at 40 C when the original broth was reconstituted is illustrated. The ability to respond was directly proportional to the measurable amount of VRS remaining, confirming the previous observation that the VRS in this strain is limiting at 40 C in TGYE broth (1) .
Protein synthesis was halted in other cultures by either tetracycline inhibition, L-iSoleucine and L-tryptophan starvation, or levallorphan tartrate inhibition (Fig. 2 ). In the first two cases, there was but a slight decline in VRS level with time; however, levellorphan treatment, which causes a drastic decline in intracellular ATP (6) , caused a dramatic inactivation of the VRS.
These experiments demonstrated that the (closed symbols). Periodically, samples were removed for determination of valyl-tRNA synthetase activity (triangles), other samples were added to complete TGYE broth at 40 C, and the initial growth rate was monitored by optical density at 420 nm. Initial growth rate at each starvation time was then expressed relative to the initial growth rate (k = 1.95 hr-') in TGYE without starvation and plotted on the ordinate as relative growth recovery (circles).
VRS level of strain NP2907 could be lowered by manipulating the L-valine and ATP levels of the cell; however, it is unlikely that the loss of either operates during growth. L-Valine is always present in excess in the medium, and this strain was shown to be permeable to L-valine under the conditions used for temperature shifts (unpublished data). Total starvation for energy sources at 40 C did not affect the level of VRS, so ATP level is probably not limiting during growth. Greene and Magasanik (6) have shown the difficulty of depressing the ATP pool by nutritional means.
These data suggested that under normal conditions of growth the VRS of strain NP2907 was thermostabile in vivo at 40 C and confirmed the findings of Yaniv and Gros (21) that L-valine and ATP confer stability upon VRS. We were tempted to conclude that the inability of this strain to accumulate VRS at 40 C was the result of an inability to synthesize VRS at this temperature. At least three different molecular bases for temperature-sensitive synthesis can be imagined. First, there might be a temperature-sensitive step in either the initiation of mRNA formation or the initiation of its translation. Second, the elongation of the VRS polypeptide chain might be halted by a temperature-induced conformational change of the folding polypeptide such that further chain elongation is inhibited. Third, newly made VRS might be more susceptible to heat inactivation than older enzyme due to a transitory lack of substrate-induced stable configurations.
We attempted to detect inactive VRS (which the second possibility would predict should accumulate at 40 C) by an immunochemical procedure. Figure 3 illustrates the immunochemical profiles of VRS antigen in crude extracts of the wild strain, NP2, of strain NP2907 grown in identical media at 30 C, and of strain NP2907 which had been al- In vivo stability of the valyl-tRNA synthetase of strain NP2907 during growth inhibition. A culture of strain NP2907 growing at 30 C in minimal medium containing L-valine (150,ug/ml) and L-isoleucine (50 jg/ml) was harvested as described in Fig.   1 , divided into three parts, and resuspended at 40 C in either: original medium plus 5 mm levallorphan tartrate (A), original medium plus 100 jg of tetracycline per ml (-), or minimal medium plus 150 ,jg of L-valine and 50 jg of 5-methyltryptophane per ml (0). Samples were taken at intervals and assayed for valyl-tRNA synthetase activity in the usual manner except that the crude extracts were exhaustively dialyzed before use. lowed to grow at 40 C until the measurable level of VRS had fallen sixfold. The profiles generated by complement fixation are analogous to curves generated by the precipitin assay. It can be seen that the VRS of both strain NP2 and NP2907 have similar equivalence points, although (as would be predicted for an altered enzyme) the VRS of strain NP2907 differed fivefold in the extent of crossreactivity to the anti-VRS antibody prepared against the wild-type enzyme. These data indicate that despite a twofold difference in the specific activity of the two extracts there are similar numbers of molecules of VRS in the two preparations. However, in the extract of strain NP2907 where the VRS level was reduced sixfold by growth at 40 C, the equiva-319 lence point was shifted somewhere to the right of the figure. The extent of this shift was not possible to estimate because extensive nonspecific complement fixation occurred at crude protein quantities beyond 10 Ag. Theoretically, the eventual equivalence point should have the same magnitude as that of the 30 C strain NP2907 extract. Despite the lack of quantitation, the data were consistent with the possibility that inactive VRS did not accumulate at 40 C. Such immunochemical data, however, rely on the unproved assumption that inactivated VRS will retain cross-reactivity, which has been shown in other instances to be invalid (9) . It was necessary to apply a more rigorous demonstration that synthesis of new VRS at 40 C did not occur.
Measurement of synthesis of VRS. The technique of detecting unlabeled de novo VRS by introducing a density label into preexisting enzyme was described above. Cultures of strain NP2907 adapted to D2O minimal medium and cultures grown normally in H20 minimal medium were harvested, and the extracts were tested for the recovery of VRS from CsCl. tained only D20-labeled VRS and banded symmetrically at a density of 1.34 g/ml; another tube contained unlabeled VRS and banded at a density of 1.30. The third tube tested the effect of unlabeled proteins upon the banding of deuterium-labeled VRS by including an equal quantity of unlabeled crude extract of strain NP29, an isogenic strain of NP2907 which contains no detectable VRS activity in vitro. There was no effect of the latter upon the banding of the labeled VRS.
When the specific activity (units/milligram of protein) of VRS in crude extracts of deuterium-labeled and unlabeled cultures of strain NP2 and NP2907 was measured, it was discovered that the labeled enzyme activity had increased relative to the unlabeled in both wild strain and mutant ( Table 1 ). The arginyltRNA synthetase was not affected, eliminating trivial reasons for the discrepancy. Either the deuterium-labeled "heavy" VRS had greater catalytic activity than unlabeled "light" enzyme, or in the presence of D2O there was an anomalous derepression of VRS synthesis. For the subsequent experiments, this difference could be compensated for, although further work is required to resolve it.
The recovery of an equal number of units of heavy and light VRS centrifuged through CsCl is shown in Fig. 5 which there is a precedent with ,B-galactosidase (7). The peak height was not affected by prolonged incubation of mixed extracts of heavy and light VRS in CsCl (not shown) and is therefore unlikely to be a result of subunit exchange. The magnitude of the peak (less than 10% of total activity) did not interfere with subsequent quantitation of individual peaks.
An experiment was designed to determine unequivocally whether new VRS was being synthesized at 40 C when net synthesis could not be demonstrated. A D2O-adapted culture of strain NP2907 growing at 30 C was shifted to 40 C in H2O minimal medium. After one mass doubling the culture was harvested, an extract was made, and a portion was subjected to isopycnic centrifugation in CsCl. Figure 6 depicts the resultant banding of VRS activity. A peak of light VRS corresponding to newly synthesized enzyme is clearly evident and means that a corresponding quantity of preexisting heavy enzyme was inactivated. The determination of the true rate of synthesis of new enzyme at 40 C, relative to the rate at 30 C, was determined according to the analysis presented above. It is evident from Table 2 that the actual differential rate of synthesis at 40 C is indistinguishable from the apparent rate of accumulation of VRS at 30 C.
Our previous report (1) C level of VRS itself should reflect a balance between these two rates. Figure 7 illustrates the result of shifting a D2O-adapted culture of strain NP2907 from 30 C back to 30 C in H2O minimal medium. After one mass doubling, the ratio of heavy to light enzyme was 1.0, but the total amount of heavy VRS per milliliter of culture had fallen, and the true rate of synthesis of VRS must be adjusted upwards by a factor of 1.42 (Table 3 ).
The differential rates of VRS synthesis in Tables 2 and 3 The fraction of VRS banding in the heavy peak was measured by means of a planimeter, and this value is presented in column 6. This value was then corrected by inflating the light peak by a factor of 1.5 to compensate for the difference in activity of deuterated and nondeuterated extracts (see Table 1 ). The corrected value for heavy VRS appears in column 7. eCalculated as the product of columns 5 and 7. ' Calculated according to equation 6 Effect of a D20-to-H20 shift at 30 C upon the density distribution of valyl-tRNA synthetase activity of strain NP2907 in a CsCI gradient. Procedure was identical with that of Fig. 6 , except that no shift was made from 30 C. After one mass doubling in H,O minimal medium, the culture was harvested, extract was made, and 1.3 mg of protein was subjected to centrifugation in CsCI. Valyl-tRNA synthetase activity (O) and refractive index (0) were measured.
in rich medium (1) . In the first case, the rate of VRS synthesis was zero, and the rate of inactivation must also have been zero. In the latter case, VRS synthesis occurred at significant rates but was exactly balanced by inactivation. That VRS synthesis should be proportional to protein synthesis is self-evident and dull, but to find that VRS inactivation should be proportional to protein synthesis is unexpected and deserving of explanation. We next investigated the possible connection that inactivation might have with the rate of growth, and specifically with protein synthesis.
Influence of substrates upon valyl-tRNA synthetase inactivation. The rate of inactivation of VRS in strain NP2907 clearly depends on some parameter set by the rate of growth. One approach to the solution of this problem was to attempt to mimic in vitro the paradox that VRS is stable under nongrowth conditions but unstable during maximal growth.
The series of experiments generating the data of Fig. 8 were performed. In one tube we placed a solution containing L-valine and ATP, but no tRNA, with the usual assay conditions which favor the maintenance of the VRSvalyl-adenylate complex. At intervals during incubation at 40 C, samples were removed and assayed for enzyme activity at 30 C. Figure 8 shows the result: the mutant VRS remained completely stable at 40 C. Yaniv and Gros (21) have reported similar effects of L-valine and ATP upon their mutant VRS in vitro. However, when tRNA was also included in the reaction mixture such that aminoacylation could occur at 40 C, the enzyme was drastically inac- Table 2 ; the actual values were: 1.10 mg of protein/ml of culture and 0.19 unit of VRS per mg of protein.
c Calculated as the product of columns 2 and 3. d The fraction of VRS banding in the heavy peak was measured by means of a planimeter, and this value is presented in column 5. This value was then corrected by inflating the light peak by a factor of 1.5 to compensate for the difference in activity of deuterated and nondeuterated extracts (see Table 1 ). The corrected value for heavy VRS appears in column 6. e Calculated as the product of columns 4 and 6. ' The differential rate of VRS synthesis (units of VRS made/mg of protein made) was calculated by adding the negative rate of heavy VRS decay (ln 0.66 = -0.42) to the observed rate of accumulation of VRS at 30 C (1.00), yielding 1.42 (21) found to stabilize VRS. These results were repeated at intermediate temperatures, at which the rate of inactivation of the enzyme in the presence of the complete reaction mixture was steadily reduced as the temperature was lowered (Fig. 9) . In fact, VRS activity actually increased somewhat when incubated at 37 C in the absence of tRNA.
There was no influence of substrates upon the stability of the VRS of strain NP2 at the temperatures used above. The enzyme was completely stable and uniform in activity.
These findings suggested that the rate of inactivation of VRS in vivo in strain NP2907 may depend upon the particular state of the enzyme vis a vis its substrates and products, which in turn may be controlled by the overall growth rate of the cells. (22) are particularly important for an understanding of the properties of strain NP2907. These workers pointed out that the rate-limiting step of aminoacylation of tRNA for the isoleucine synthetase (IRS) is most likely, from kinetic evidence, the release of isoleucyl-tRNA from the ternary complex, IRS-ile-AMP-iletRNA11e, when ATP, isoleucine, and tRNA are saturating. The similarity in kinetic constants of the VRS and IRS (20) suggests that this is most likely true for the VRS as well. Therefore, during most in vivo conditions, the VRS exists with bound valyl-AMP.
DISCUSSION
This information has led us to propose a model with the following features. (i) The predominant functional state of the VRS in vivo and in vitro (usual assay conditions) is the ternary complex, VRS-val-AMP-valylAtRNAval.
In vivo, under nongrowth conditions in which protein synthesis is halted but L-valine is present in excess, this state is probably the only one possible. As determined experimentally, the VRS must be completely thermostable. Drastically decreasing either the Lvaline or ATP concentrations permits inactivation. (ii) The flux of valyl-tRNA in protein synthesis continuously regenerates tRNAVal. Since there is little difference in affinity in the binding of acylated and deacylated tRNAVal to the VRS (20) , the fate of the ternary complex is dependent upon the relative concentrations of the two species, that is, the ratio of deacylated to acylated tRNAVal. When the ratio of tRNAVal to valyl-tRNAval approaches zero, exchange occurs as follows: VRS-val-AMP-valyl-tRNA ; VRS-val-AMP + valyl-tRNA. Since the complex, VRS-val-AMP, remains intact, the resulting conformational change in the enzyme would be preserved. However, when the inverse ratio, valyl-tRNAval to tRNAval, approaches zero, the ternary complex is entrained in the cycle of aminoacylation shown in Fig. 10 , and the enzyme sustains continuous changes in conformation as the complex breaks down and reforms. This situation is approximated by the in vitro assay conditions, at least initially, wherein the VRS is extremely susceptible to inactivation at elevated temperatures, as experimentally noted. (iii) At intermediate values of tRNAval/valylAtRNAval, the probability of inactivation of the VRS at a particular temperature is found between the two extremes: Vd = f(tRNAval/valyl-tRNAval) (7) (iv) The overall rate of protein synthesis at a particular temperature determines the tRNAVaI to valyl-tRNAval ratio [since the ratio of total tRNA to total protein is nearly constant in E. coli (10) ], where k = specific growth rate constant, (8) tRNAval/valyl-tRNAval = f(k) Therefore, combining (7) and (8) Vd = f(k) The rate of inactivation of VRS is then coordinated with the rate of growth, as experimentally indicated.
The central feature to this model is that the mutant VRS undergoes inactivation as a consequence of its functioning. Specifically, the transition from state H to state Ill, as shown in In state I, the enzyme (large circle) has valyl-adenylate (val-AMP) bound to it. In state II, a v'aline-specific tRNA has bound to the enzyme. This complex degrades into state III by the formation of valyl-tRNA, still bound to the enzyme, and the release of AMP. New molecules of ATP and valine next bind to the enzyme, forming state IV which has both valyl-adenylate and valyl-tRNA bound to it. Finally, dissociation of val-tRNA yields state I again. This latter step in the model of Yarus and Berg (22) for isoleucyl-tRNA synthetase is the rate-limiting one. We postulate that it is the change from II to III that leads to inactivation of the mutant VRS.
is known about the behavior of this enzyme in vivo.
The cellular environment may also have a profound effect upon the stability of wild-type aminoacyl-tRNA synthetases in certain circumstances. Williams and Neidhardt (19) have reported that cycles of "feast and famine" during discontinuous feeding of E. coli in chemostat cultures limited by amino acid supply cause extensive inactivation of the respective aminoacyl-tRNA synthetase. Cells completely starved for amino acid lose synthetase activity at a far lower rate, and cells limited in growth by slow but continuous generation of intracellular amino acid do not lose synthetase at all. The first set of conditions generates a different pattern of substrate-enzyme complexes than those reported here, and these may contribute to extremely unfavorable oscillations of the aminoacyl-tRNA synthetases between unstable states.
The possible role that various functional states of aminoacyl-tRNA synthetases may play in intracellular regulatory mechanisms needs further exploration.
